HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 21 to 40 of 43
< previous   next >
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
articleTakahashi, Kiyohiko; Nakamura, Akinobu; Miyoshi, Hideaki; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Shimizu, Chikara; Taguri, Masataka; Terauchi, Yasuo; Atsumi, TatsuyaFactors associated with an inadequate hypoglycemia in the insulin tolerance test in Japanese patients with suspected or proven hypopituitarism-Endocrine Journal-Apr-2017
articleCho, Kyu Yong; Nakamura, Akinobu; Omori, Kazuno; Takase, Takahiro; Miya, Aika; Yamamoto, Kohei; Nomoto, Hiroshi; Kameda, Hiraku; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiFavorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone-Journal of Diabetes Investigation-8-Jul-2021
articleOe, Yuki; Kameda, Hiraku; Nomoto, Hiroshi; Sakamoto, Keita; Soyama, Takeshi; Cho, Kyu Yong; Nakamura, Akinobu; Iwasaki, Koji; Abo, Daisuke; Kudo, Kohsuke; Miyoshi, Hideaki; Atsumi, TatsuyaFavorable effects of burosumab on tumor-induced osteomalacia caused by an undetectable tumor A case report-Medicine-19-Nov-2021
articleCho, Kyu Yong; Nomoto, Hiroshi; Nakamura, Akinobu; Kawata, Shinichiro; Sugawara, Hajime; Takeuchi, Jun; Nagai, So; Tsuchida, Kazuhisa; Omori, Kazuno; Yokoyama, Hiroki; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiFavourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation : An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study)-Diabetes, Obesity and Metabolism-Mar-2020
articleOmori, Kazuno; Nakamura, Akinobu; Miyoshi, Hideaki; Yamauchi, Yuki; Kawata, Shinichiro; Takahashi, Kiyohiko; Kitao, Naoyuki; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Terauchi, Yasuo; Atsumi, TatsuyaGlucokinase Inactivation Paradoxically Ameliorates Glucose Intolerance by Increasing beta-Cell Mass in db/db Mice-Diabetes-Apr-2021
articleTsuchida, Kazuhisa; Nakamura, Akinobu; Miyoshi, Hideaki; Yang, Kelaier; Yamauchi, Yuki; Kawata, Shinichiro; Omori, Kazuno; Takahashi, Kiyohiko; Kitao, Naoyuki; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Seino, Yusuke; Terauchi, Yasuo; Atsumi, TatsuyaGlucokinase is required for high-starch diet-induced beta-cell mass expansion in mice-Journal of diabetes investigation-Sep-2021
articleCho, Kyu Yong; Miyoshi, Hideaki; Nakamura, Akinobu; Kurita, Takashi; Atsumi, TatsuyaHyponatremia can be a powerful predictor of the development of isolated ACTH deficiency associated with nivolumab treatment-Endocrine Journal-Feb-2017
articleMiya, Aika; Nakamura, Akinobu; Cho, Kyu Yong; Kawata, Shinichiro; Nomoto, Hiroshi; Nagai, So; Sugawara, Hajime; Taneda, Shinji; Tsuchida, Kazuhisa; Omori, Kazuno; Yokoyama, Hiroki; Takeuchi, Jun; Aoki, Shin; Kurihara, Yoshio; Atsumi, Tatsuya; Miyoshi, HideakiImpact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients type 2 diabetes treated with canagliflozin plus teneligliptin-Journal of Diabetes Investigation-10-Aug-2021
articleMiya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Miyoshi, Hideaki; Atsumi, TatsuyaImpaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment-Journal of diabetes investigation-May-2021
articleCho, Kyu Yong; Nomoto, Hiroshi; Nakamura, Akinobu; Kawata, Shinichiro; Sugawara, Hajime; Takeuchi, Jun; Nagai, So; Omori, Kazuno; Tsuchida, Kazuhisa; Miya, Aika; Shigesawa, Ikumi; Tsuchida, Kenichi; Yanagiya, Shingo; Kameda, Hiraku; Yokoyama, Hiroki; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Nishimoto, Naoki; Atsumi, Tatsuya; Miyoshi, HideakiImproved Time in Range and Postprandial Hyperglycemia with Canagliflozin in Combination with Teneligliptin : Secondary Analyses of the CALMER study-Journal of Diabetes Investigation-10-Aug-2021
articleTakase, Takahiro; Nakamura, Akinobu; Yamamoto, Chiho; Nomoto, Hiroshi; Miya, Aika; Dannoura, Midori; Cho, Kyu Yong; Kurihara, Yoshio; Manda, Naoki; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiImprovement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes : A randomized controlled trial-Journal of Diabetes Investigation-May-2019
articleMiya, Aika; Nakamura, Akinobu; Handa, Takahisa; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Ito, Yoichi M.; Miyoshi, Hideaki; Atsumi, TatsuyaLog-linear relationship between endogenous insulin secretion and glycemic variability in patients with type 2 diabetes on continuous glucose monitoring-Scientific reports-27-Apr-2021
articleYamamoto, Kohei; Miyoshi, Hideaki; Cho, Kyu Yong; Nakamura, Akinobu; Greenberg, Andrew S.; Atsumi, TatsuyaOverexpression of perilipin1 protects against atheroma progression in apolipoprotein E knockout mice-Atherosclerosis-Feb-2018
articleCho, Kyu Yong; Miyoshi, Hideaki; Kuroda, Satoshi; Yasuda, Hiroshi; Kamiyama, Kenji; Nakagawara, Joji; Takigami, Masayoshi; Kondo, Takuma; Atsumi, TatsuyaThe phenotype of infiltrating macrophages influences arteriosclerotic plaque vulnerability in the carotid artery-Journal of stroke and cerebrovascular diseases-Oct-2013
articleOmori, Kazuno; Nomoto, Hiroshi; Nakamura, Akinobu; Takase, Takahiro; Cho, Kyu Yong; Ono, Kota; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, HideakiReduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide : A randomized controlled trial of repaglinide vs sulfonylurea-Journal of Diabetes Investigation-Mar-2019
article (author version)Kitao, Naoyuki; Nakamura, Akinobu; Miyoshi, Hideaki; Nomoto, Hiroshi; Takahashi, Kiyohiko; Omori, Kazuno; Yamamoto, Kohei; Cho, Kyu Yong; Terauchi, Yasuo; Atsumi, TatsuyaThe role of glucokinase and insulin receptor substrate-2 in the proliferation of pancreatic beta cells induced by short-term high-fat diet feeding in mice-Metabolism-Aug-2018
articleOita, Mayuko; Miyoshi, Hideaki; Ono, Kota; Nakamura, Akinobu; Cho, Kyu Yong; Nomoto, Hiroshi; Yamamoto, Kohei; Omori, Kazuno; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, TatsuyaSatisfaction and efficacy of switching from daily dipeptidyl peptidase-4 inhibitors to weekly trelagliptin in patients with type 2 diabetes : Randomized controlled study-Endocrine Journal-Feb-2018
articleMiya, Aika; Nakamura, Akinobu; Miyoshi, Hideaki; Cho, Kyu Yong; Nagai, So; Kurihara, Yoshio; Aoki, Shin; Taguri, Masataka; Terauchi, Yasuo; Atsumi, TatsuyaSatisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy : A randomized controlled trial-Journal of Diabetes Investigation-Jan-2018
articleYamauchi, Yuki; Kameda, Hiraku; Omori, Kazuno; Tani, Michio; Cho, Kyu Yong; Nakamura, Akinobu; Miyoshi, Hideaki; Tanaka, Shinya; Atsumi, TatsuyaSevere infection including disseminated herpes zoster triggered by subclinical Cushing's disease: a case report-BMC Endocrine Disorders-27-Apr-2021
articleTakahashi, Kiyohiko; Cho, Kyu Yong; Nakamura, Akinobu; Miya, Aika; Miyoshi, Arina; Yamamoto, Chiho; Nomoto, Hiroshi; Niwa, Hirokatsu; Takahashi, Kiyohito; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Ito, Yoichi M; Atsumi, Tatsuya; Miyoshi, HideakiShould sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes-Journal of Diabetes Investigation-Mar-2019
Showing results 21 to 40 of 43
< previous   next >

 

Hokkaido University